The Canadian Society of Nephrology Methods for Developing and Adapting Clinical Practice Guidelines: An Update.

IF 1.6 Q3 UROLOGY & NEPHROLOGY
Canadian Journal of Kidney Health and Disease Pub Date : 2025-06-30 eCollection Date: 2025-01-01 DOI:10.1177/20543581251346074
Somaya Zahran, Anna Mathew, Tyrone G Harrison, Arenn Jauhal, Michelle A Hladunewich, Reem A Mustafa
{"title":"The Canadian Society of Nephrology Methods for Developing and Adapting Clinical Practice Guidelines: An Update.","authors":"Somaya Zahran, Anna Mathew, Tyrone G Harrison, Arenn Jauhal, Michelle A Hladunewich, Reem A Mustafa","doi":"10.1177/20543581251346074","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose of the review: </strong>In this article, we provide an update on the Canadian Society of Nephrology's (CSN) process of identifying candidate topics and subsequent development of guidelines and commentaries using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE)-ADOLOPMENT methodology. We revise the process of adapting existing guidelines with the inclusion of Kidney Disease Improving Global Outcomes (KDIGO) practice points. We also describe challenges of implementing guidelines and suggest solutions to address this with description of the CSN approach to disseminating and implementing guidelines.</p><p><strong>Sources of information: </strong>The update reflects internal CSN documentation, stakeholder consultation for topic prioritization, and integration of methodological guidance from GRADE-ADOLOPMENT and international sources such as KDIGO.</p><p><strong>Methods: </strong>We reviewed and synthesized the CSN's current guideline-development process, which includes a detailed examination of internal documentation, meeting summaries, and publicly available methodological frameworks with specific focus on the application of the GRADE-ADOLOPMENT approach. We analyzed how recommendations and practice points from KDIGO are assessed for relevance, updated based on Canadian context, and integrated into the final commentary using GRADE Evidence-to-Decision (EtD) frameworks. We also examined how conflict of interest is managed, how working groups are structured, and how recommendations are prioritized. In addition, we explored the CSN's evolving strategies for dissemination and implementation, including stakeholder engagement, survey feedback, and use of knowledge-translation tools.</p><p><strong>Key findings: </strong>The CSN follows a transparent and rigorous process in guideline and commentary development. This comprehensive process considers the best-available evidence, balancing desirable and undesirable effects and patients' values, perspectives, and implications for the Canadian health care system including resources, equity, acceptability, and feasibility to maximize guideline implementation and advance the health of Canadians.</p><p><strong>Limitations: </strong>The CSN updated methods reflect the current process and may not be generalizable to other guideline organizations. The impact of CSN commentaries on clinical practice, decision-making, and policy uptake has not been formally evaluated, limiting our understanding of their contribution to health system improvement and patient outcomes.</p><p><strong>Implications: </strong>This review updates the CSN's processes for commentary working groups to identify relevant international guidelines, establish the level of agreement on included recommendations, incorporate perspectives of people with lived experience, and adjust the final product to the Canadian healthcare system before dissemination.</p>","PeriodicalId":9426,"journal":{"name":"Canadian Journal of Kidney Health and Disease","volume":"12 ","pages":"20543581251346074"},"PeriodicalIF":1.6000,"publicationDate":"2025-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12214302/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Canadian Journal of Kidney Health and Disease","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/20543581251346074","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose of the review: In this article, we provide an update on the Canadian Society of Nephrology's (CSN) process of identifying candidate topics and subsequent development of guidelines and commentaries using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE)-ADOLOPMENT methodology. We revise the process of adapting existing guidelines with the inclusion of Kidney Disease Improving Global Outcomes (KDIGO) practice points. We also describe challenges of implementing guidelines and suggest solutions to address this with description of the CSN approach to disseminating and implementing guidelines.

Sources of information: The update reflects internal CSN documentation, stakeholder consultation for topic prioritization, and integration of methodological guidance from GRADE-ADOLOPMENT and international sources such as KDIGO.

Methods: We reviewed and synthesized the CSN's current guideline-development process, which includes a detailed examination of internal documentation, meeting summaries, and publicly available methodological frameworks with specific focus on the application of the GRADE-ADOLOPMENT approach. We analyzed how recommendations and practice points from KDIGO are assessed for relevance, updated based on Canadian context, and integrated into the final commentary using GRADE Evidence-to-Decision (EtD) frameworks. We also examined how conflict of interest is managed, how working groups are structured, and how recommendations are prioritized. In addition, we explored the CSN's evolving strategies for dissemination and implementation, including stakeholder engagement, survey feedback, and use of knowledge-translation tools.

Key findings: The CSN follows a transparent and rigorous process in guideline and commentary development. This comprehensive process considers the best-available evidence, balancing desirable and undesirable effects and patients' values, perspectives, and implications for the Canadian health care system including resources, equity, acceptability, and feasibility to maximize guideline implementation and advance the health of Canadians.

Limitations: The CSN updated methods reflect the current process and may not be generalizable to other guideline organizations. The impact of CSN commentaries on clinical practice, decision-making, and policy uptake has not been formally evaluated, limiting our understanding of their contribution to health system improvement and patient outcomes.

Implications: This review updates the CSN's processes for commentary working groups to identify relevant international guidelines, establish the level of agreement on included recommendations, incorporate perspectives of people with lived experience, and adjust the final product to the Canadian healthcare system before dissemination.

加拿大肾脏病学会发展和适应临床实践指南的方法:更新。
综述的目的:在这篇文章中,我们提供了加拿大肾脏病学会(CSN)使用分级推荐、评估、发展和评价(GRADE)-采用方法确定候选主题和随后制定指南和评论的最新进展。我们修改了适应现有指南的过程,纳入了肾病改善全球预后(KDIGO)实践要点。我们还描述了实施指南的挑战,并通过描述CSN传播和实施指南的方法,提出了解决这一问题的解决方案。信息来源:此次更新反映了CSN内部文件、利益相关方对主题优先次序的咨询,以及来自level - adolopdevelopment和国际来源(如KDIGO)的方法指导的整合。方法:我们回顾并综合了CSN目前的指导方针制定过程,其中包括对内部文件、会议摘要和公开可用的方法框架的详细审查,并特别关注grade - adolopdevelopment方法的应用。我们分析了如何评估KDIGO的建议和实践要点的相关性,根据加拿大的情况进行更新,并使用GRADE证据到决策(EtD)框架将其整合到最终评论中。我们还研究了如何管理利益冲突,如何组织工作组,以及如何确定建议的优先级。此外,我们还探讨了CSN在传播和实施方面不断发展的战略,包括利益相关者参与、调查反馈和知识翻译工具的使用。主要发现:CSN在指南和评论的制定过程中遵循透明和严格的流程。这一综合过程考虑了可获得的最佳证据,平衡了可取和不可取的效果以及患者的价值观、观点和对加拿大卫生保健系统的影响,包括资源、公平性、可接受性和可行性,以最大限度地实施指南并促进加拿大人的健康。局限性:CSN更新的方法反映了当前的过程,可能不能推广到其他指南组织。CSN评论对临床实践、决策和政策采纳的影响尚未得到正式评估,限制了我们对其对卫生系统改进和患者预后的贡献的理解。意义:本综述更新了CSN评论工作组的流程,以确定相关的国际指南,建立对所包括建议的一致程度,纳入有生活经验的人的观点,并在传播前调整最终产品以适应加拿大医疗保健系统。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.00
自引率
5.90%
发文量
84
审稿时长
12 weeks
期刊介绍: Canadian Journal of Kidney Health and Disease, the official journal of the Canadian Society of Nephrology, is an open access, peer-reviewed online journal that encourages high quality submissions focused on clinical, translational and health services delivery research in the field of chronic kidney disease, dialysis, kidney transplantation and organ donation. Our mandate is to promote and advocate for kidney health as it impacts national and international communities. Basic science, translational studies and clinical studies will be peer reviewed and processed by an Editorial Board comprised of geographically diverse Canadian and international nephrologists, internists and allied health professionals; this Editorial Board is mandated to ensure highest quality publications.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信